David Boothe

Global Commercial Leader

Back to Speakers

David Boothe is the Global Commercial Lead for Inherited and Metabolic Disorders within the Rare Diseases Unit at GSK. He has commercial responsibility for a broad franchise that has spanned amyloidoses, lysosomal storage disorders (LSDs) and pulmonary arterial hypertension (PAH) from pre-clinical development through to maturity. David has a wealth of experience in the rare and orphan diseases fi eld having joined GSK from Shire Human Genetics Therapies in Switzerland where he served as EMEA Product Director in Fabry Disease. Prior to Shire, David worked in international marketing roles for BioMarin and before that Oxford GlycoSciences, in MPS VI and Gaucher disease respectively.